Pulse Biosciences, Inc.

NASDAQ:PLSE

Medical - Instruments & Supplies

Healthcare
$45.83 +3.83%

+$0.97 today

Market cap
$3.37B
Beta
1.66
P/E (TTM)
-24.0
EPS (TTM)
-$1.10
52W Low $12.56High $28.53

Volume 0.33M

Average 0.31M

PLSE Other Current Assets

Current assets not reported separately, such as prepaid expenses.

Pulse Biosciences, Inc.NASDAQ: PLSE

Other Current Assets · Q2 FY2026 · quarter ended Jun 2026

Other current assets rises 111.5% from a year ago

Other current assets stood at $3.72M at the end of Q2 FY2026, up 111.5% from a year earlier and up 52.0% from the prior quarter. Over 3 fiscal years it compounded at +31.2% a year.

Context

  • Other current assets amounted to 3.2% of total assets at the end of Q2 FY2026, up 1.8 pp from a year earlier.
  • Other current assets increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether other current assets keeps rising in the next quarterly balance sheet after a +111.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$3.72M+52.0% QoQ
Last fiscal yearDec 2025
$2.28M+61.3% YoY
Year agoJun 2025
$1.76M+111.5% since
Other Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+111.5%——
1 year+61.3%——
3-year CAGR+31.2%——
5-year CAGR——
10-year CAGR——

Other Current Assets history

USD · from the balance sheet

Latest · FY2025
2.28M USD
Year-over-year change
+61.3%

Other Current Assets vs competitors

How PLSE compares with its peers on the latest reported figures

  • Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +111.5% is the 5th highest of 10, against a peer median of +73.1%.
  • Other current assets amounts to 3.2% of total assets for PLSE, versus a peer median of 0.5%.
PLSE Competitors
Other Current Assets for PLSE and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NVCRNovoCure LimitedMar 2026$53.13M USD+2368.9%+256.9%6.7%
ATAIAtai Beckley Inc.Jun 2026$18.19M USD+1270.5%-18.5%6.9%
IMTXImmatics N.V.Mar 2026€17.61M EUR+56.3%+2.4%3.2%
OPKOPKO Health, Inc.Mar 2026$9.76M USD-90.0%+9.3%0.5%
LFMDLifeMD, Inc.Mar 2026$3.86M USD+73.1%+56.8%5.5%
PLSEPulse Biosciences, Inc.Jun 2026$3.72M USD+111.5%+31.2%3.2%
KMTSKestra Medical Technologies, Ltd.Jan 2026$1.49M USD+241.7%—0.4%
STAASTAAR Surgical CompanyApr 2026$851K USD+192.4%+114.8%0.2%
BBNXBeta Bionics, Inc.Mar 2026$351K USD+35.0%-26.3%0.1%
DNTHDianthus Therapeutics, Inc.Jun 2026$184K USD+65.8%+356.5%0.0%
NKTRNektar TherapeuticsJun 2026$0 USD——0.0%
Peer median (excluding PLSE) —+73.1%+33.0%0.5%

Competitors are the stored peer set for PLSE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents28.61M61.14M44.37M118.04M80.74M
Short-term Investments00000
Net Receivables61K000274K
Inventory5.82M000136K
Other Current Assets01.01M963K1.41M2.28M
Total Current Assets36.63M62.15M45.33M119.45M83.42M
Property, Plant & Equipment (Net)11.25M10.02M8.78M8.32M7.06M
Goodwill2.79M2.79M2.79M2.79M2.79M
Intangible Assets3.22M2.55M1.89M1.22M575K
Long-term Investments(3.26M)(2.73M)1.89M00
Tax Assets3.26M2.73M001.58M
Other Non-current Assets365K365K(1.52M)677K691K
Total Non-current Assets17.62M15.73M13.83M13.01M12.69M
Total Assets54.25M77.88M59.15M132.46M96.11M
Account Payables2.9M1.57M1.84M1.67M2.78M
Short-term Debt436K917K001.57M
Tax Payables00000
Deferred Revenue16K0000
Other Current Liabilities1.46M50K3.2M1.2M1.6M
Total Current Liabilities8.52M5.98M6.71M10.06M7.92M
Long-term Debt065M000
Deferred Tax Liabilities00001.58M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities10.04M74.14M8.09M7.54M7.54M
Total Liabilities18.56M80.13M14.79M17.6M15.46M
Common Stock29K37K55K66K68K
Retained Earnings(236.2M)(294.71M)(336.92M)(390.5M)(463.28M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity35.69M(2.25M)44.36M114.86M80.66M
Total Debt11.25M75.96M9.14M8.9M7.53M
Net Debt(17.36M)14.82M(35.22M)(109.14M)(73.21M)

Pulse Biosciences, Inc.

NASDAQ:PLSE

Intrinsic Alpha fair value

Locked

Current Price

$45.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.